 |
 |

Left Atrium Size and the Risk of Cardiovascular Death in Middle-aged Men
Jari A. Laukkanen, MD;
Sudhir Kurl, MD;
Jaakko Eränen, MD;
Matti Huttunen, MD;
Jukka T. Salonen, MD, PhD, MScPH
Arch Intern Med. 2005;165:1788-1793.
Background The echocardiographic identification of subclinical risk markers may enhance risk stratification for the development of cardiovascular outcomes in the general population. Although echocardiography is widely used in the evaluation of cardiac structures and function, the prognostic value of echocardiographic assessment of left atrium (LA) size for risk stratification of cardiovascular death is unknown.
Methods Left ventricular (LV) mass and LA size were measured by using M-mode echocardiography in a representative population-based sample of 830 men (age, 42-61 years) from eastern Finland. There were 54 deaths due to cardiovascular disease during an average follow-up of 13 years.
Results The strongest risk factors for cardiovascular death were smoking, family history of coronary heart disease, low exercise capacity, elevated blood pressure, exercise-induced myocardial ischemia, and large LA diameter. Men in the highest tertile of LA diameter (>43 mm) had a 2.3-fold (95% confidence interval, 1.1-5.0) risk of cardiovascular death compared with men in the lowest tertile of LA diameter (<39 mm), after adjusting for other risk factors and the use of antihypertensive medications. The excess risk for cardiovascular mortality appeared to reside largely in the highest tertile of LA size. After additional adjustment for LV mass, the relation between LA size and mortality did not remain statistically significant (relative risk, 1.5; 95% confidence interval, 0.8-4.1; P = .15) in this group.
Conclusions This prospective population-based study shows that echocardiographically defined LA diameter was directly related to the risk of cardiovascular death. The association of LA enlargement to cardiovascular death appears to be partially related to LV hypertrophy.
Author Affiliations: Research Institute of Public Health (Drs Laukkanen, Kurl, Eränen, and Salonen) and the Department of Public Health and General Practice (Dr Salonen), University of Kuopio, Kuopio; and Savonlinna Central Hospital, Savonlinna (Drs Laukkanen and Huttunen); Finland.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members: et al.
Eur Heart J 2007;0:ehm236v1-75.
FULL TEXT
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
Gerdts et al.
Hypertension 2007;49:311-316.
ABSTRACT
| FULL TEXT
Peak oxygen pulse during exercise as a predictor for coronary heart disease and all cause death
Laukkanen et al.
Heart 2006;92:1219-1224.
ABSTRACT
| FULL TEXT
Left Atrial Size: Physiologic Determinants and Clinical Applications
Abhayaratna et al.
J Am Coll Cardiol 2006;47:2357-2363.
ABSTRACT
| FULL TEXT
|